—CAMMARATA HONORED BY HEALTHCARE TECHNOLOGY
REPORT—
LAVAL, QC, March 2, 2021 /CNW Telbec/ - Neptune Wellness
Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX:
NEPT) President and CEO Michael
Cammarata has been named one of the Top 25 Biotech CEOs of
2021 by The Healthcare Technology Report.
Mr. Cammarata has led Neptune Wellness Solutions Inc., a
diversified and fully integrated health and wellness company
focused on natural, plant-based, sustainable and purpose-driven
lifestyle brands, since 2019.
"I'm honored to be acknowledged alongside some of the most
revolutionary thought leaders in the biotech industry today," said
Michael Cammarata, President and
Chief Executive Officer of Neptune Wellness Solutions Inc. "This
honor would not be possible without the brilliant and resilient
Neptune team, whose passion for health and wellness drives us
forward and makes life-changing breakthroughs possible--even, and
especially, when faced with the unprecedented challenges of the
past year."
The Top 25 Biotech CEOs of 2021 are recognized for the
"remarkable strides" they have made in areas including vaccine
development, oncology, regenerative medicine, vascular disease,
autoimmune disease, pain management, and neurodegenerative disease,
according to The Healthcare Technology Report. They were
selected from hundreds of nominees.
"The past twelve months, more than any other period in recent
history, have showcased the outstanding talent, ingenuity, and
determination of the world's leading biotechnology executives and
their organizations," The Healthcare Technology Report said
in a statement. "Responding proactively to the day's most pressing
needs, these CEOs lean in, take on daunting risks head-on, and
boldly charge forth for the benefit of healing not only the
vulnerable segments of our population but in some cases humanity at
large."
The other honorees are Stéphane Bancel of Moderna Therapeutics,
Allen Eaves of STEMCELL
Technologies, Ugur Sahin of
BioNTech, Michael Chambers of
Aldevron, Charles Brown of LifeLabs,
Amit Munshi of Arena
Pharmaceuticals, Ryan Watts of
Denali Therapeutics, Adam Grossman
of ADMA Biologics, Scott Hutton of
Biodesix, John Houston of Arvinas,
Jeffrey Bailey of BioDelivery
Sciences International, Mike Raab of
Ardelyx, Brian McKelligon of Akoya
Biosciences, Joseph Payne of
Arcturus Therapeutics, Michael
Bailey of AVEO Oncology, Adi
Hoess of Affimed NV, Al
Altomari of Agile Therapeutics, Eliot Forster of F-star Therapeutics,
James Dentzer of Curis Inc.,
Vipin K. Garg of Altimmune,
Joseph Hagan of Regulus Therapeutics
Inc., Bruce Steel of Equillium,
Frederic Guerard of Graybug Vision,
and Tillman Gerngross of Adagio
Therapeutics.
For more information on Neptune Wellness Solutions Inc, visit
www.neptunecorp.com.
ABOUT NEPTUNE WELLNESS SOLUTIONS INC.:
Neptune Wellness Solutions is a unique global health and
wellness company that is changing consumer habits through the
creation and distribution of environmentally friendly, ethical and
innovative consumer product goods. Neptune's simultaneous focus on
B2C and B2B customer-oriented brand development provides the
Company with international reach and scale from its owned and
operated facilities that extract and create product formulation,
all the way to the sales floor at top global retailers. Underpinned
by a disruptive spirit, Neptune's diversified, and fully integrated
business
model focuses on natural, plant-based, sustainable and purpose-driven lifestyle brands and
the use of cannabinoids in household products to make them safer,
healthier and more effective. Its portfolio includes emerging
brands such as Forest Remedies™, Ocean
Remedies™, Neptune Wellness™, Mood Ring™, and OCEANO3™, which are poised for
rapid growth and expansion. Backed with a cost-efficient
manufacturing and supply chain infrastructure that can be scaled up
and down or into adjacent product categories to identify new
innovation opportunities, Neptune quickly adapts to consumer
preferences and demand, and is bringing its products as well as
other Fortune 100 brands to market through strategic distribution
partnerships, mass retail partners and e-commerce channels. Neptune
is committed to its core mission of redefining health and wellness
and helping humanity thrive by providing sustainable consumer
focused solutions. For additional information, please
visit: www.neptunecorp.com
Forward Looking Statements:
Statements in this press release that are not statements of
historical or current fact constitute "forward-looking statements"
within the meaning of the U.S. securities laws and Canadian
securities laws. Such forward-looking statements involve known and
unknown risks, uncertainties, and other unknown factors that could
cause the actual results of Neptune to be materially different from
historical results or from any future results expressed or implied
by such forward-looking statements. In addition to statements which
explicitly describe such risks and uncertainties, readers are urged
to consider statements labeled with the terms "believes", "belief",
"expects", "intends", "projects", "anticipates", "will", "should"
or "plans" to be uncertain and forward-looking. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press
release.
The forward looking statements contained in this press release
are expressly qualified in their entirety by this cautionary
statement and the "Cautionary Note Regarding Forward-Looking
Information" section contained in Neptune's latest Annual
Information Form (the "AIF"), which also forms part of Neptune's
latest annual report on Form 40-F, and which is available on SEDAR
at www.sedar.com, on EDGAR
at www.sec.gov/edgar.shtml and on the investor section of
Neptune's website at www.neptunecorp.com. All forward-looking
statements in this press release are made as of the date of this
press release. Neptune does not undertake to update any such
forward-looking statements whether as a result of new information,
future events or otherwise, except as required by law. The
forward-looking statements contained herein include, without
limitation, statements about the fulfillment of purchase orders,
the availability of products from Neptune's supplier, and the
anticipated use of proceeds of the financing and other risks and
uncertainties that are described from time to time in Neptune
public securities filings with the Securities and Exchange
Commission and the Canadian securities commissions. Additional
information about these assumptions and risks and uncertainties is
contained in the AIF under "Risk Factors".
Neither NASDAQ nor the Toronto Stock Exchange accepts
responsibility for the adequacy or accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/neptune-wellness-solutions-inc-president-michael-cammarata-named-top-25-biotech-ceo-301238083.html
SOURCE Neptune Wellness Solutions Inc.